| For: | Shah K, Curtin BF, Chu C, Hwang D, Flasar MH, von Rosenvinge E. Characteristics of Clostridium difficile infection in patients hospitalized with myelodysplastic syndrome or acute myelogenous leukemia. World J Clin Oncol 2017; 8(5): 398-404 [PMID: 29067276 DOI: 10.5306/wjco.v8.i5.398] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v8/i5/398.htm |
| Number | Citing Articles |
| 1 |
Jianbiao Zhou, Wee-Joo Chng. Resistance to FLT3 inhibitors in acute myeloid leukemia: Molecular mechanisms and resensitizing strategies. World Journal of Clinical Oncology 2018; 9(5): 90-97 doi: 10.5306/wjco.v9.i5.90
|
| 2 |
Aaron C Miller, Alan T Arakkal, Daniel K Sewell, Alberto M Segre, Joseph Tholany, Philip M Polgreen. Comparison of Different Antibiotics and the Risk for Community-Associated Clostridioides difficile Infection: A Case–Control Study. Open Forum Infectious Diseases 2023; 10(8) doi: 10.1093/ofid/ofad413
|
| 3 |
Olivier Ballo, Eva-Maria Kreisel, Fagr Eladly, Uta Brunnberg, Jan Stratmann, Peter Hunyady, Michael Hogardt, Thomas A. Wichelhaus, Volkhard A. J. Kempf, Björn Steffen, Joerg J. Vehreschild, Maria J. G. T. Vehreschild, Fabian Finkelmeier, Hubert Serve, Christian H. Brandts. Use of carbapenems and glycopeptides increases risk for Clostridioides difficile infections in acute myeloid leukemia patients undergoing intensive induction chemotherapy. Annals of Hematology 2020; 99(11) doi: 10.1007/s00277-020-04274-1
|
| 4 |
Yuan-Pin Hung, Chin-Shiang Tsai, Bo-Yang Tsai, Pei-Jane Tsai, Yuan-Ti Lee, Jen-Chieh Lee, Hsiu-Chuan Liu, Po-Ren Hsueh, Ching-Chi Lee, Wen-Chien Ko. Clostridioides difficile infection in patients with hematological malignancy: A multicenter study in Taiwan. Journal of Microbiology, Immunology and Infection 2021; 54(6) doi: 10.1016/j.jmii.2021.02.002
|
| 5 |
Hamzah Abu-Sbeih, Kati Choi, Cynthia N. Tran, Xuemei Wang, Phillip Lum, Gladis Shuttlesworth, John R. Stroehlein, Pablo C. Okhuysen, Yinghong Wang. Recurrent Clostridium difficile infection is associated with treatment failure and prolonged illness in cancer patients. European Journal of Gastroenterology & Hepatology 2019; 31(1) doi: 10.1097/MEG.0000000000001288
|
| 6 |
Eisaku Iwanaga, Hirotomo Nakata, Rie Furuta, Kenji Tokunaga, Jun-Ichirou Yasunaga. Fulminant Clostridioides difficile Infection During Repeated High-Dose Cytarabine Consolidation for Acute Myeloid Leukemia: A Fatal Case. Cureus 2026; doi: 10.7759/cureus.102177
|
| 7 |
Maria Cecília Freire de Melo, Thuanny Silva de Macedo, Julianelly Alves Biserra, Karina Luz Cavalcanti Rodrigues, Mônica Cruz, Aurora Karla de Lacerda Vidal. The use of antimicrobial photodynamic therapy in oral injuries of a pediatric patient with myelodysplastic syndrome: case report. Special Care in Dentistry 2018; 38(2) doi: 10.1111/scd.12275
|
| 8 |
Chiara Oltolini, Agnieszka Piekarska, Alessio Signori, Christine Robin, Dionysios Neofytos, Elena Reigadas, Lidia Gil, Roy Chemaly, Andreas H. Groll, Patricia Munoz, Benjamin W. Teh, Malgorzata Mikulska. Clostridioides difficile infection in non-transplanted adults with haematological malignancy: Systematic review and meta-analysis on behalf of European Conference on Infections in Leukemia (ECIL) and Infectious Diseases Working Party (IDWP) of the European Society for Blood and Marrow Transplantation (EBMT). Blood Reviews 2026; doi: 10.1016/j.blre.2026.101396
|
| 9 |
Clyde D. Ford, Bert K. Lopansri, Brandon J. Webb, Jana Coombs, Launce Gouw, Julie Asch, Daanish Hoda. Clostridioides difficile colonization and infection in patients with newly diagnosed acute leukemia: Incidence, risk factors, and patient outcomes. American Journal of Infection Control 2019; 47(4) doi: 10.1016/j.ajic.2018.09.027
|
| 10 |
Christopher C. Battaglia, Kaye Hale. Hospital-Acquired Infections in Critically Ill Patients With Cancer. Journal of Intensive Care Medicine 2019; 34(7) doi: 10.1177/0885066618788019
|
| 11 |
Abdulrahman Alamri, AlHanoof Bin Abbas, Ekram Al Hassan, Yasser Almogbel. Development of a Prediction Model to Identify the Risk of Clostridioides difficile Infection in Hospitalized Patients Receiving at Least One Dose of Antibiotics. Pharmacy 2024; 12(1) doi: 10.3390/pharmacy12010037
|